ACIU compared with XOMA: revenue, margins and what each company keeps, and the suppliers and customers both name

ACIUAC Immune SA

Mkt capRevenueRevenue

XOMAXOMA Royalty Corp

Mkt capRevenueRevenue

Compare

ACIUAC Immune SA

XOMAXOMA Royalty Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

ACIU

No earnings history for ACIU.

XOMA

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q1 FY26±17.0%▲+1.30%×0.08

Mar 2 '26±22.0%▲+2.66%×0.12

Q3 FY25±12.3%▼−2.52%×0.20

Aug 13 '25±9.9%▲+8.54%×0.86

= impliedACIU realized, solidXOMA realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

ACIUAC Immune SA

2.07▼−6.58%

Mkt cap$222.9MRevenue—Revenue—

XOMAXOMA Royalty Corp

39.35▼−11.01%

Regular sessionNov 2 '26

Mkt cap$503.8MRevenue$12MQ1 FY26Revenue$52MFY25

Compare

Regular sessionNov 2 '26

ACIUAC Immune SA

XOMAXOMA Royalty Corp

2.07▼−6.58%

Price

39.35▼−11.01%

$222.9M

Mkt cap

$503.8M

—

Revenue

$12MQ1 FY26

—

Revenue

$52MFY25

ACIU2.07▼−6.58%vsXOMA39.35▼−11.01%Regular sessionNov 2 '26